Related Experiment Videos
In vitro bactericidal activity of daptomycin against staphylococci
Peter C Fuchs1, Arthur L Barry, Steven D Brown
1The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070, USA. cmi@hevanet.com
The Journal of Antimicrobial Chemotherapy
|February 28, 2002
Summary
Daptomycin demonstrated the most potent bactericidal activity against staphylococcal isolates compared to vancomycin, linezolid, and quinupristin-dalfopristin (Q-D). This study highlights daptomycin
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Staphylococcal infections pose a significant threat due to rising antimicrobial resistance.
- Evaluating the comparative efficacy of key antibiotics is crucial for effective treatment strategies.
Purpose of the Study:
- To determine and compare the in vitro antimicrobial and bactericidal activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin (Q-D) against staphylococcal isolates.
Main Methods:
- Minimum Inhibitory Concentrations (MICs) and Minimum Bactericidal Concentrations (MBCs) were determined for 108 staphylococcal isolates.
- Time-kill assays were conducted on 25 selected isolates to assess bactericidal kinetics.
Main Results:
- All isolates were susceptible to daptomycin and Q-D. Daptomycin exhibited the lowest geometric mean MBC (0.57 mg/L).
- Daptomycin demonstrated rapid and broad bactericidal activity, achieving >99.9% kill in 92% of strains tested at 2 mg/L or 2x MBC.
- Comparative time-kill tests showed daptomycin significantly outperformed vancomycin, linezolid, and Q-D in terms of bactericidal rates.
Conclusions:
- Daptomycin possesses superior bactericidal activity against staphylococcal isolates compared to vancomycin, linezolid, and Q-D.
- The findings support daptomycin's role as a key therapeutic option for staphylococcal infections, particularly those involving resistant strains.